GFD

intradermal human Fcγ1-Fel d1 fusion protein · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GFD, covering 2014-02-20 to 2014-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy [EARLY_Phase 1]

See pricing